UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2022-06, Vol.22 (6), p.382-392

2022

Volltextzugriff (PDF)

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone

Annals of hematology, 2017-02, Vol.96 (2), p.253-259

2017

Volltextzugriff (PDF)

Phase I study of peptide receptor radionuclide therapy with [ 111In-DTPA 0]octreotide: The rotterdam experience

Seminars in nuclear medicine, 2002-04, Vol.32 (2), p.110-122

2002

Volltextzugriff (PDF)

Treatment and survival of primary effusion lymphoma (PEL): A population‐based study among 25 patients diagnosed in the Netherlands between 2002 and 2015

Hematological oncology, 2017-06, Vol.35 (S2), p.342-342

2017

Volltextzugriff (PDF)

Primary Results of the Health-Related Quality of Life Assessment from the Phase III Gadolin Study of Obinutuzumab Plus Bendamustine Compared with Bendamustine Alone in Patients with Rituximab-Refractory, Indolent Non-Hodgkin Lymphoma

BLOOD, 2015-12, Vol.126 (23), p.1532-1532

2015

Volltextzugriff (PDF)

Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics

Clinical epidemiology, 2018-01, Vol.10, p.1523-1531

2018

Volltextzugriff (PDF)

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

BLOOD, 2018-11, Vol.132 (Supplement 1), p.998-998

2018

Volltextzugriff (PDF)

Multiple venous aneurysms in a patient with hypereosinophilic syndrome

Phlebology, 2016-02, Vol.31 (1), p.66-68

2016

Volltextzugriff (PDF)

FDG‐PET as a Biomarker of Response in DLBCL: the HOVON 84 Study Experience

Hematological oncology, 2017-06, Vol.35 (S2), p.40-41

2017

Volltextzugriff (PDF)

COMBINED RISK OF SECOND MALIGNANT NEOPLASMS AND CARDIOVASCULAR DISEASE IN LONG‐TERM HODGKIN LYMPHOMA SURVIVORS

Hematological oncology, 2017-06, Vol.35 (S2), p.67-68

2017

Volltextzugriff (PDF)

RITUXIMAB SC AND IV PLUS CHOP SHOW SIMILAR EFFICACY AND SAFETY IN THE RANDOMISED MABEASE STUDY IN FIRST‐LINE DLBCL

Hematological oncology, 2017-06, Vol.35 (S2), p.185-186

2017

Volltextzugriff (PDF)

Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO database

European journal of cancer care, 2015-03, Vol.24 (2), p.232-241

2015

Volltextzugriff (PDF)

Attendance to HODGKIN lymphoma survivorship care clinics in the Netherlands

Hematological oncology, 2017-06, Vol.35 (S2), p.309-309

2017

Volltextzugriff (PDF)

Molecular immunoglobulin/T- cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol

Haematologica (Roma), 2003-06, Vol.88 (6), p.659

2003

Volltextzugriff (PDF)

Cost-effectiveness of rituximab (MabThera®) in diffuse large B-cell lymphoma in the Netherlands

European journal of haematology, 2005-03, Vol.74 (3), p.194-202

2005

Volltextzugriff (PDF)

Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin's Lymphomas

The Journal of nuclear medicine (1978), 2001-02, Vol.42 (2), p.222-229

2001

Volltextzugriff (PDF)

Somatostatin receptor scintigraphy useful in stage I–II Hodgkin's disease: more extended disease identified

British journal of haematology, 2001-03, Vol.112 (4), p.936-944

2001

Volltextzugriff (PDF)

Aplastic anaemia: a review

Netherlands journal of medicine, 2003-05, Vol.61 (5), p.157-163

2003

Volltextzugriff (PDF)

Clonal identity between skin and synovial tissue in a case of mycosis fungoides with polyarthritis

Journal of the American Academy of Dermatology, 2004-07, Vol.51 (1), p.111-117

2004

Volltextzugriff (PDF)

Visualization of the thymus by substance P receptor scintigraphy in man

European Journal of Nuclear Medicine, 1996-11, Vol.23 (11), p.1508-1513

1996

Volltextzugriff (PDF)

Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease

British journal of haematology, 1996-04, Vol.93 (1), p.96-103

1996

Volltextzugriff (PDF)

The relevance of somatostatin receptor expression in malignant lymphomas

Metabolism, clinical and experimental, 1996-08, Vol.45 (8 Suppl 1), p.96-97

1996

Volltextzugriff (PDF)

Somatostatin receptor scintigraphy in cutaneous malignant lymphomas

Journal of the American Academy of Dermatology, 1996-06, Vol.34 (6), p.985-993

1996

Volltextzugriff (PDF)

Comparative tumorigenicity of the cyclopenta-fused polycyclic aromatic hydrocarbons aceanthrylene, dihydroaceanthrylene and acephenanthrylene in preweanling CD-1 and BLU:Ha mouse bioassays

Carcinogenesis (New York), 1999-06, Vol.20 (6), p.1137-1141

1999

Volltextzugriff (PDF)

Short-segment jejunal stenosis complicating subacute portomesenteric venous thrombosis in a patient with protein S deficiency type II

The American journal of gastroenterology, 1996-08, Vol.91 (8), p.1653-1654

1996

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(21)
Humans
(18)
Biological And Medical Sciences
(11)
Female
(11)
Male
(11)
Medical Sciences
(10)
Middle Aged
(10)
Hematology
(8)
Adult
(7)
Aged
(7)
Hematologic And Hematopoietic Diseases
(5)
Lymphoma
(5)
Neoplasm Staging
(5)
Prospective Studies
(5)
Receptors, Somatostatin - Analysis
(5)
Investigative Techniques, Diagnostic Techniques
(4)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(4)
Oncology
(4)
Radionuclide Imaging
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma

Health-related quality of life and symptoms in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated in the phase III GADOLIN study with obinutuzumab plus bendamustine versus bendamustine alone

Phase I study of peptide receptor radionuclide therapy with [ 111In-DTPA 0]octreotide: The rotterdam experience

Treatment and survival of primary effusion lymphoma (PEL): A population‐based study among 25 patients diagnosed in the Netherlands between 2002 and 2015

Primary Results of the Health-Related Quality of Life Assessment from the Phase III Gadolin Study of Obinutuzumab Plus Bendamustine Compared with Bendamustine Alone in Patients with Rituximab-Refractory, Indolent Non-Hodgkin Lymphoma

Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

Multiple venous aneurysms in a patient with hypereosinophilic syndrome

FDG‐PET as a Biomarker of Response in DLBCL: the HOVON 84 Study Experience

COMBINED RISK OF SECOND MALIGNANT NEOPLASMS AND CARDIOVASCULAR DISEASE IN LONG‐TERM HODGKIN LYMPHOMA SURVIVORS

RITUXIMAB SC AND IV PLUS CHOP SHOW SIMILAR EFFICACY AND SAFETY IN THE RANDOMISED MABEASE STUDY IN FIRST‐LINE DLBCL

Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO database

Attendance to HODGKIN lymphoma survivorship care clinics in the Netherlands

Molecular immunoglobulin/T- cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol

Cost-effectiveness of rituximab (MabThera®) in diffuse large B-cell lymphoma in the Netherlands

Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin's Lymphomas

Somatostatin receptor scintigraphy useful in stage I–II Hodgkin's disease: more extended disease identified

Aplastic anaemia: a review

Clonal identity between skin and synovial tissue in a case of mycosis fungoides with polyarthritis

Visualization of the thymus by substance P receptor scintigraphy in man

Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease

The relevance of somatostatin receptor expression in malignant lymphomas

Somatostatin receptor scintigraphy in cutaneous malignant lymphomas

Comparative tumorigenicity of the cyclopenta-fused polycyclic aromatic hydrocarbons aceanthrylene, dihydroaceanthrylene and acephenanthrylene in preweanling CD-1 and BLU:Ha mouse bioassays

Short-segment jejunal stenosis complicating subacute portomesenteric venous thrombosis in a patient with protein S deficiency type II

Suchergebnisse filtern